A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2009
11/04/2009	EP2113249A1 Antimycotic patch
11/04/2009	EP2113247A2 High efficiency encapsulation of nucleic acids in lipid vesicles
11/04/2009	EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009	EP2112999A1 Non-natural recombinant gelatins with enhanced functionality
11/04/2009	EP2112924A1 Delta 9 - tetrahydrocannabinol processing
11/04/2009	EP2112921A1 A controlled release composition
11/04/2009	EP1848458B1 Use of activated polymers for separation of protein and polypeptide multimers
11/04/2009	EP1729823B1 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
11/04/2009	EP1490121B1 Drug delivery particle
11/04/2009	EP1480736B1 Microcapsules having high carotenoid content
11/04/2009	EP1471151B1 Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora.
11/04/2009	EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009	EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009	EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/04/2009	CN101573133A PEGylated, extended insulins
11/04/2009	CN101573111A Formulations of phospholipase enzyme inhibitors
11/03/2009	US7612214 Organic amine salts of glutamic acid derivatives and their application
11/03/2009	US7612176 Polymer-based sustained release device
11/03/2009	US7612172 Immunization; used to elicit a humoral or cellular immune response
11/03/2009	US7612142 high molecular weight crosslinked polyethylene glycol binded to cyclodextrin molecule, capped with steroids, or adamantane groups; solvent absorbers; changes in swelling property with change in pH; high speed response to a change of the surrounding electric field
11/03/2009	US7612115 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability
11/03/2009	US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009	US7612109 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
11/03/2009	US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009	US7612066 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
11/03/2009	US7612058 Administering 1-(4-fluorophenyl)-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl)]-4(S)-[4-(phenylmethoxy)phenyl]-2-azetidinone; and peroxisome proliferator-activated receptor activator; obesity, antidiabetic agents
11/03/2009	US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009	US7612016 Preparation of superabsorbent polymers
11/03/2009	US7611864 Proinsulin polypeptide-oligomer conjugates
11/03/2009	US7611729 Dosage forms having prolonged active ingredient release
11/03/2009	US7611727 Pharmaceutical composition for transdermal or transmucous administration
11/03/2009	US7611725 Additives and products including oligoesters
11/03/2009	US7611722 Reduced contact of the active ingredient in solid form with the mucosa lining the gastrointestinal tract, which is particularly advantageous for delivering an ulcerative drug.
11/03/2009	US7611721 Adjuvant combination formulations
11/03/2009	US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009	US7611706 RG1 antibodies and uses thereof
11/03/2009	CA2527686C Cellulose powder
11/03/2009	CA2520450C Polymeric modifiers that improve the bioavailability of protein drugs and pharmaceutical compositions thereof
11/03/2009	CA2514224C Liquid pharmaceutical formulations of palonosetron
11/03/2009	CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
11/03/2009	CA2448035C New pharmaceutical composition
11/03/2009	CA2447924C Olopatadine formulations for topical administration
11/03/2009	CA2424579C Ultraviolet-screening patch
11/03/2009	CA2418008C Antifungal ketoconazole composition for topical use
11/03/2009	CA2415272C Improvements in and relating to the use of honey in dressings
11/03/2009	CA2404210C Pharmaceutical gel composition
11/03/2009	CA2402401C Compositions containing molecular iodine
11/03/2009	CA2402222C Sustained release ranolazine formulations
11/03/2009	CA2397832C Acrylic enteric coating compositions
11/03/2009	CA2383220C Controlled release pellet formulation
11/03/2009	CA2324283C Pharmaceutical composition containing a statin and aspirin
11/03/2009	CA2213663C Polyalkylene block copolymers as surface modifiers for nanoparticles
11/03/2009	CA2205379C Yeast-based delivery vehicles
10/2009
10/29/2009	WO2009132294A1 Polymeric artificial tear system
10/29/2009	WO2009132228A1 Chitosan-containing protective composition
10/29/2009	WO2009132226A1 Thiolated chitosan gel
10/29/2009	WO2009132131A1 Amino lipid based improved lipid formulation
10/29/2009	WO2009132050A2 Auris formulations for treating otic diseases and conditions
10/29/2009	WO2009132048A2 Treating eosinophilic esophagitis
10/29/2009	WO2009131695A1 Oligomer-bis-chromonyl compound conjugates
10/29/2009	WO2009131435A1 Linker containing bungarotoxin and a binding peptide
10/29/2009	WO2009131216A1 Lipid membrane structure modified with oligo(alkylene glycol)
10/29/2009	WO2009130564A1 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias
10/29/2009	WO2009130517A2 Method and compound for tracking micrometastases of prostate androgen receptors
10/29/2009	WO2009130394A1 Gastroresistant cyclosporin formulation
10/29/2009	WO2009130342A1 Improved pharmaceutical composition containing ibuprofen and codeine
10/29/2009	WO2009130261A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009	WO2009130048A1 Stabilized liquid formulation
10/29/2009	WO2009129943A1 Formulation with reduced hygroscopicity
10/29/2009	WO2009129694A1 A new micelle formulation compriseing prostaglandin e1 entrapmented by polyglycol-derived phospholipid
10/29/2009	WO2009129627A1 Novel resveratrol compositions
10/29/2009	WO2009129592A1 Liquid formulation for deferiprone with palatable taste
10/29/2009	WO2009106831A3 Pharmaceutical composition comprising naltrexone
10/29/2009	WO2009103932A8 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain
10/29/2009	WO2009101320A3 Fine powder of polyamide from renewable materials and method for making such powder
10/29/2009	WO2009099719A3 Compositions and methods for the treatment of tumor of hematopoietic origin
10/29/2009	WO2009098450A3 Methods and compositions
10/29/2009	WO2009065022A3 Low density lipoprotein receptor-mediated sirna delivery
10/29/2009	WO2009005839A3 Conjugates of compounds binding the steroid hormone receptor and their use as anticancer drugs
10/29/2009	US20090270859 Fluid compositions and methods for the use thereof
10/29/2009	US20090270516 Process for Producing Optically Active Theaspirane
10/29/2009	US20090270515 Active ingredient containing stabilised solid medicinal forms and method for the production thereof
10/29/2009	US20090270514 Methods for Regulating Gelation of Polysaccharide Solutions and Uses Thereof
10/29/2009	US20090270441 Macrolides
10/29/2009	US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins
10/29/2009	US20090270308 Controlled release implantable dispensing device and method
10/29/2009	US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009	US20090269404 Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods
10/29/2009	US20090269401 Controlled Release Solid Preparation
10/29/2009	US20090269398 Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
10/29/2009	US20090269384 Bioactive thermogelling polymer systems and methods of their use
10/29/2009	US20090269374 Cosmetic compositions for improving the performance of transfer-resistant and long-wearing
10/29/2009	US20090269361 Constructs for delivery of therapeutic agents to neuronal cells
10/29/2009	US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009	US20090269328 Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion
10/29/2009	US20090269316 Methods for Using a Three-Dimensional Stromal Tissue to Promote Angiogenesis
10/29/2009	US20090269298 Agent for the prevention and treatment of sexually transmitted diseases-i
10/29/2009	US20090269277 Multivalent Immunoglobulin-Based Bioactive Assemblies
10/29/2009	US20090266467 Bioabsorbable Surgical Composition
10/29/2009	DE202008008059U1 Zusammensetzung zur Prophylaxe und Therapie der Arthrose Composition for the prophylaxis and treatment of osteoarthritis

1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1712